Correction of hypothermic and dilutional coagulopathy with concentrates of fibrinogen and factor XIII: An in vitro study with ROTEM

Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine

Volumn 22, Issue 1, 2014, Pages

  Winstedt, Dag ^a,b   Thomas, Owain D ^a,b   Nilsson, Fredrik ^b   Olanders, Knut ^a,b   Schött, Ulf ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Factor XIII; Fibrinogen; Hemodilution; Hemostasis; Hypothermia; Thrombelastography

Indexed keywords

BLOOD CLOTTING FACTOR 13; FIBRINOGEN; HETASTARCH DERIVATIVE;

ADULT; AGED; BLOOD; BLOOD CLOTTING TEST; BLOOD COAGULATION DISORDERS; COMPLICATION; FEMALE; HUMAN; HYPOTHERMIA; MALE; METABOLISM; MIDDLE AGED; NORMAL HUMAN; PROCEDURES; THROMBOELASTOGRAPHY;

ADULT; AGED; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; FACTOR XIII; FEMALE; FIBRINOGEN; HEALTHY VOLUNTEERS; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; HYPOTHERMIA; MALE; MIDDLE AGED; THROMBELASTOGRAPHY;

EID: 84989295852     PISSN: None     EISSN: 17577241     Source Type: Journal    
DOI: 10.1186/s13049-014-0073-z     Document Type: Article

References (43)

1. Brohi K, Singh J, Heron M, Coats T: Acute traumatic coagulopathy. J Trauma 2003, 54:1127-1130.
2. Wolberg AS, Meng ZH, Monroe DM 3rd, Hoffman M: A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function. J Trauma 2004, 56:1221-1228.
3. Bolliger D, Gorlinger K, Tanaka KA: Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology 2010, 113:1205-1219.
4. Darlington DN, Kremenevskiy I, Pusateri AE, Scherer MR, Fedyk CG, Kheirabaldi BS, Delgado AV, Dubick MA: Effects of In vitro hemodilution, hypothermia and rFVIIa addition on coagulation in human blood. Int J Burns Trauma 2012, 2:42-50.
5. Gubler KD, Gentilello LM, Hassantash SA, Maier RV: The impact of hypothermia on dilutional coagulopathy. J Trauma 1994, 36:847-851.
6. Fries D, Innerhofer P, Reif C, Streif W, Klingler A, Schobersberger W, Velik-Salchner C, Friesenecker B: The effect of fibrinogen substitution on reversal of dilutional coagulopathy: an in vitro model. Anesth Analg 2006, 102:347-351.
7. Haas T, Fries D, Velik-Salchner C, Reif C, Klingler A, Innerhofer P: The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution. Anesth Analg 2008, 106:1360-1365.
8. Schlimp CJ, Cadamuro J, Solomon C, Redl H, Schochl H: The effect of fibrinogen concentrate and factor XIII on thromboelastometry in 33% diluted blood with albumin, gelatine, hydroxyethyl starch or saline in vitro. Blood Transfus 2013, 11:510-517.
9. Winstedt D, Tynngard N, Olanders K, Schott U: Free oscillation rheometry monitoring of haemodilution and hypothermia and correction with fibrinogen and factor XIII concentrates. Scand J Trauma Resusc Emerg Med 2013, 21:20.
10. The R Project for Statistical Computing [www.r-project.org].
11. Pinheiro J, Bates D, DebRoy S, Sarkar D: Linear and Nonlinear Mixed Effects Models. R Package 2013, Version 3.1.
12. Hothorn T, Bretz F, Westfall P: Simultaneous inference in general parametric models. Biom J 2008, 50:346-363.
13. Benjamini Y, Hochberg Y: Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J R Statist Soc B 1995, 57:289-300.
14. Lang T, Bauters A, Braun SL, Potzsch B, von Pape KW, Kolde HJ, Lakner M: Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinolysis 2005, 16:301-310.
15. Dirkmann D, Hanke AA, Gorlinger K, Peters J: Hypothermia and acidosis synergistically impair coagulation in human whole blood. Anesth Analg 2008, 106:1627-1632.
16. Kettner SC, Sitzwohl C, Zimpfer M, Kozek SA, Holzer A, Spiss CK, Illievich UM: The effect of graded hypothermia (36 degrees C-32 degrees C) on hemostasis in anesthetized patients without surgical trauma. Anesth Analg 2003, 96:1772-1776.
17. Rundgren M, Engstrom M: A thromboelastometric evaluation of the effects of hypothermia on the coagulation system. Anesth Analg 2008, 107:1465-1468.
18. Caballo C, Escolar G, Diaz-Ricart M, Lopez-Vilchez I, Lozano M, Cid J, Pino M, Beltran J, Basora M, Pereira A, Galan AM: Impact of experimental haemodilution on platelet function, thrombin generation and clot firmness: effects of different coagulation factor concentrates. Blood Transfus 2013, 11:391-399.
19. Nielsen VG: Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions. Acta Anaesthesiol Scand 2005, 49:1163-1171.
20. Casutt M, Kristoffy A, Schuepfer G, Spahn DR, Konrad C: Effects on coagulation of balanced (130/0.42) and non-balanced (130/0.4) hydroxyethyl starch or gelatin compared with balanced Ringer's solution: an in vitro study using two different viscoelastic coagulation tests ROTEM and SONOCLOT. Br J Anaesth 2010, 105:273-281.
21. Hartog CS, Reuter D, Loesche W, Hofmann M, Reinhart K: Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review. Intensive Care Med 2011, 37:1725-1737.
22. Weiss G, Lison S, Spannagl M, Heindl B: Expressiveness of global coagulation parameters in dilutional coagulopathy. Br J Anaesth 2010, 105:429-436.
23. Ruttmann TG, James MF, Viljoen JF: Haemodilution induces a hypercoagulable state. Br J Anaesth 1996, 76:412-414.
24. Ruttmann TG, Jamest MF, Lombard EH: Haemodilution-induced enhancement of coagulation is attenuated in vitro by restoring antithrombin III to pre-dilution concentrations. Anaesth Intensive Care 2001, 29:489-493.
25. MacDonald SG, Luddington RJ: Critical factors contributing to the thromboelastography trace. Semin Thromb Hemost 2010, 36:712-722.
26. Ng KF, Cheung CW, Lee Y, Leung SW: Low-dose desmopressin improves hypothermia-induced impairment of primary haemostasis in healthy volunteers. Anaesthesia 2011, 66:999-1005.
27. Franz A, Braunlich P, Gamsjager T, Felfernig M, GustorffB, Kozek-Langenecker SA: The effects of hydroxyethyl starches of varying molecular weights on platelet function. Anesth Analg 2001, 92:1402-1407.
28. Liu FC, Liao CH, Chang YW, Liou JT, Day YJ: Hydroxyethyl starch interferes with human blood ex vivo coagulation, platelet function and sedimentation. Acta Anaesthesiol Taiwan 2009, 47:71-78.
29. Petroianu GA, Maleck WH, Koetter KP, Liu J, Schmitt A: Effect of in vitro hemodilution with hydroxyethyl starch and dextran on the activity of plasma clotting factors. Crit Care Med 2003, 31:250-254.
30. De Lorenzo C, Calatzis A, Welsch U, Heindl B: Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6%. Anesth Analg 2006, 102:1194-1200.
31. Winstedt D, Hanna J, Schott U: Albumin-induced coagulopathy is less severe and more effectively reversed with fibrinogen concentrate than is synthetic colloid-induced coagulopathy. Scand J Clin Lab Invest 2013, 73:161-169.
32. Krause KR, Howells GA, Buhs CL, Hernandez DA, Bair H, Schuster M, Bendick PJ: Hypothermia-induced coagulopathy during hemorrhagic shock. Am Surg 2000, 66:348-354.
33. Hanke AA, Dellweg C, Schochl H, Weber CF, Juttner B, Johanning K, Gorlinger K, Rahe-Meyer N, Kienbaum P: Potential of whole blood coagulation reconstitution by desmopressin and fibrinogen under conditions of hypothermia and acidosis-an in vitro study using rotation thrombelastometry. Scand J Clin Lab Invest 2011, 71:292-298.
34. Schramko AA, Kuitunen AH, Suojaranta-Ylinen RT, Niemi TT: Role of fibrinogen-, factor VIII-and XIII-mediated clot propagation in gelatin haemodilution. Acta Anaesthesiol Scand 2009, 53:731-735.
35. Theusinger OM, Baulig W, Asmis LM, Seifert B, Spahn DR: In vitro factor XIII supplementation increases clot firmness in Rotation Thromboelastometry (ROTEM). Thromb Haemost 2010, 104:385-391.
36. Faraday N, Rosenfeld BA: In vitro hypothermia enhances platelet GPIIb-IIIa activation and P-selectin expression. Anesthesiology 1998, 88:1579-1585.
37. Scharbert G, Kalb ML, Essmeister R, Kozek-Langenecker SA: Mild and moderate hypothermia increases platelet aggregation induced by various agonists: a whole blood in vitro study. Platelets 2010, 21:44-48.
38. Li YF, Spencer FA, Becker RC: Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition. Am Heart J 2002, 143:725-732.
39. Shams Hakimi C, Fagerberg Blixter I, Hansson EC, Hesse C, Wallen H, Jeppsson A: Effects of fibrinogen and platelet supplementation on clot formation and platelet aggregation in blood samples from cardiac surgery patients. Thromb Res 2014, 134:895-900.
40. Lang T, Toller W, Gutl M, Mahla E, Metzler H, Rehak P, Marz W, Halwachs-Baumann G: Different effects of abciximab and cytochalasin D on clot strength in thrombelastography. J Thromb Haemost 2004, 2:147-153.
41. Thomas O, Gustafsson A, Schott U: Rotational thromboelastometry and multiple electrode platelet aggregometry in four patients with abnormal routine coagulation studies before removal of epidural catheters after major surgery: a case series and research study. J Med Case Reports 2013, 7:282.
42. Evans PA, Hawkins K, Lawrence M, Williams RL, Barrow MS, Thirumalai N, Williams PR: Rheometry and associated techniques for blood coagulation studies. Med Eng Phys 2008, 30:671-679.
43. Ogawa S, Szlam F, Bolliger D, Nishimura T, Chen EP, Tanaka KA: The impact of hematocrit on fibrin clot formation assessed by rotational thromboelastometry. Anesth Analg 2012, 115:16-21.